Valuation : IDEXX Laboratories, Inc.

Market Cap 4.37TCr 3.77TCr 3.53TCr 3.22TCr 6.07TCr 4,17900Cr 6.09TCr 42TCr 16TCr 2,10900Cr 16TCr 16TCr 6,99400Cr P/E 2026 *
37.6x
P/E 2027 * 33.2x
Enterprise Value 4.41TCr 3.8TCr 3.56TCr 3.25TCr 6.13TCr 4,21400Cr 6.15TCr 42TCr 16TCr 2,12700Cr 17TCr 16TCr 7,05300Cr EV / Sales 2026 *
9.33x
EV / Sales 2027 * 8.49x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : IDEXX Laboratories, Inc.

1 day-0.49%
1 week+0.72%
Current month-0.69%
1 month-1.22%
3 months-1.47%
6 months-11.42%
Current year-17.91%
1 week 472.5
Extreme 472.5
488.2
1 month 469.1
Extreme 469.1
519.4
Current year 452.2
Extreme 452.2
629
1 year 452.2
Extreme 452.2
664.6
3 years 381.3
Extreme 381.3
664.6
5 years 381.3
Extreme 381.3
664.6
10 years 161.6
Extreme 161.6
664.6
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+0.72% - - 4.37TCr
+1.82%-0.35%-14.23%+8.65% 4.37TCr
Average +0.67%-0.35%-14.23%+8.65% 4.37TCr
Weighted average by Cap. +0.67%-0.35%-14.23%+8.65%

Financials

2026 *2027 *
Net sales 472.42Cr 407.08Cr 381.68Cr 348.42Cr 656.37Cr 45TCr 658.46Cr 4.53TCr 1.77TCr 23TCr 1.77TCr 1.74TCr 76TCr 514.03Cr 442.94Cr 415.3Cr 379.11Cr 714.18Cr 49TCr 716.45Cr 4.93TCr 1.92TCr 25TCr 1.93TCr 1.89TCr 82TCr
Net income 117.88Cr 101.58Cr 95Cr 87Cr 163.78Cr 11TCr 164.3Cr 1.13TCr 440.85Cr 5.69TCr 442.57Cr 432.94Cr 19TCr 131.44Cr 113.26Cr 106.19Cr 97Cr 182.62Cr 13TCr 183.2Cr 1.26TCr 491.58Cr 6.34TCr 493.49Cr 482.76Cr 21TCr
Net Debt 37Cr 32Cr 30Cr 27Cr 51Cr 3.52TCr 51Cr 352.74Cr 137.63Cr 1.78TCr 138.16Cr 135.16Cr 5.89TCr -9.73Cr -8.39Cr -7.86Cr -7.18Cr -14Cr -930.3Cr -14Cr -93Cr -36Cr -469.61Cr -37Cr -36Cr -1.56TCr
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
28/26/28 477.10 +1.19% 0
27/26/27 €471.50 -0.21% 3
26/26/26 €472.50 0.00% 0
25/26/25 €472.50 -0.78% 0
24/26/24 €476.20 +0.53% 4
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
554.99USD
Average target price
698.92USD
Spread / Average Target
+25.93%

Quarterly revenue - Rate of surprise